Latest Period
Q1 2026
Security Snapshot
Sana Biotechnology, Inc. - Common Stock, $0.0001 par value per share (SANA) Institutional Ownership
CUSIP: 799566104
13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026
Institutions Reporting
199
Shares (Excl. Options)
164,084,278
Price
$2.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- SANA on Nasdaq
- Shares outstanding
- 297,619,048
- Price per share
- $3.26
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 164,084,278
- Total reported value
- $472,643,191
- % of total 13F portfolios
- 0%
- Share change
- +5,252,835
- Value change
- +$13,124,299
- Number of holders
- 199
- Price from insider filings
- $3.26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- SANA - Sana Biotechnology, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 799566104.
- 199 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 201 to 199 between Q4 2025 and Q1 2026.
- Reported value moved from $647,601,557 to $472,643,191.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 199 institutions filings for Q1 2026.
Security key
799566104
Latest holder period
Q1 2026
13F holders
199
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
SANA full holder history
Sana Biotechnology, Inc. SEC filings
Sana Biotechnology, Inc. company facts
Sana Biotechnology, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 799566104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
SANA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P. | 17% | $163,630,594 | 46,093,125 | Robert Nelsen | 30 Sep 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 6.3% | $61,125,000 | 18,750,000 | RA Capital Management, L.P. | 14 May 2026 | |||
| BlackRock, Inc. | 5.1% | +4% | $55,528,247 | +$10,647,588 | 13,643,304 | +24% | BlackRock, Inc. | 31 Dec 2025 |
| VANGUARD GROUP INC | 4.8% | $19,023,535 | 10,747,760 | The Vanguard Group | 31 Dec 2024 |
As of 31 Mar 2026, 199 institutional investors reported holding 164,084,278 shares of Sana Biotechnology, Inc. - Common Stock, $0.0001 par value per share (SANA). This represents 55% of the company’s total 297,619,048 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
50%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 13% | 37,430,284 | 0% | 0.01% | $107,799,219 |
| Flagship Pioneering, LLC | 8.4% | 25,001,856 | 0% | 6.2% | $72,005,346 |
| BlackRock, Inc. | 4.8% | 14,240,175 | +0.12% | 0% | $41,011,704 |
| STATE STREET CORP | 3.5% | 10,538,086 | +31% | 0% | $30,349,688 |
| CANADA PENSION PLAN INVESTMENT BOARD | 3.4% | 10,221,900 | -0.2% | 0.02% | $29,439,072 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5% | 7,434,724 | 0% | 0% | $21,412,005 |
| BAILLIE GIFFORD & CO | 2.2% | 6,609,065 | 0% | 0.02% | $19,034,107 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 4,181,973 | +1.6% | 0% | $12,046,360 |
| Marex Group plc | 1.3% | 3,999,100 | +7.1% | 0.12% | $11,517,408 |
| Integral Health Asset Management, LLC | 1.1% | 3,200,000 | +6.7% | 0.49% | $9,216,000 |
| GOLDMAN SACHS GROUP INC | 1.1% | 3,181,115 | +114% | 0% | $9,161,611 |
| BANK OF AMERICA CORP /DE/ | 0.99% | 2,946,861 | +148% | 0% | $8,486,960 |
| Alphabet Inc. | 0.94% | 2,812,500 | 0% | 0.2% | $8,100,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.57% | 1,707,521 | 0% | 0% | $4,917,660 |
| MILLENNIUM MANAGEMENT LLC | 0.53% | 1,591,030 | +155% | 0% | $4,582,166 |
| NORTHERN TRUST CORP | 0.5% | 1,478,851 | +5.1% | 0% | $4,259,092 |
| MORGAN STANLEY | 0.49% | 1,460,015 | +14% | 0% | $4,204,843 |
| RENAISSANCE TECHNOLOGIES LLC | 0.49% | 1,451,200 | -14% | 0.01% | $4,179,456 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.46% | 1,366,148 | -2.4% | 0% | $3,934,506 |
| UBS Group AG | 0.46% | 1,355,289 | +15% | 0% | $3,903,233 |
| Woodline Partners LP | 0.44% | 1,317,932 | +0.02% | 0.01% | $3,795,644 |
| TWO SIGMA INVESTMENTS, LP | 0.4% | 1,198,579 | -24% | 0% | $3,451,908 |
| AQR CAPITAL MANAGEMENT LLC | 0.38% | 1,124,279 | -0.89% | 0% | $3,237,924 |
| VANGUARD FIDUCIARY TRUST CO | 0.36% | 1,063,649 | 0% | 0% | $3,063,309 |
| Balyasny Asset Management L.P. | 0.35% | 1,033,804 | -38% | 0.01% | $2,977,356 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q1 2026
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 164,084,278 | $472,643,191 | +$13,124,299 | $2.88 | 199 |
| 2025 Q4 | 159,112,907 | $647,601,557 | -$17,518,558 | $4.07 | 201 |
| 2025 Q3 | 163,544,919 | $580,597,886 | +$66,158,610 | $3.55 | 175 |
| 2025 Q2 | 145,417,350 | $397,022,759 | -$12,602,331 | $2.73 | 152 |
| 2025 Q1 | 149,116,670 | $250,510,959 | -$14,520,086 | $1.68 | 156 |
| 2024 Q4 | 157,928,176 | $257,417,788 | -$2,121,232 | $1.63 | 159 |
| 2024 Q3 | 153,260,123 | $637,634,346 | +$16,640,858 | $4.16 | 150 |
| 2024 Q2 | 148,167,660 | $809,021,070 | +$44,986 | $5.46 | 144 |
| 2024 Q1 | 146,274,865 | $1,462,752,586 | +$233,741,262 | $10.00 | 151 |
| 2023 Q4 | 124,526,898 | $508,113,977 | -$12,215,240 | $4.08 | 128 |
| 2023 Q3 | 127,513,989 | $493,495,510 | -$30,211,194 | $3.87 | 132 |
| 2023 Q2 | 134,904,538 | $804,023,148 | +$26,527,612 | $5.96 | 121 |
| 2023 Q1 | 130,716,654 | $427,414,965 | +$6,519,444 | $3.27 | 118 |
| 2022 Q4 | 128,403,041 | $507,152,945 | -$769,516 | $3.95 | 119 |
| 2022 Q3 | 128,339,963 | $769,886,255 | +$13,983,486 | $6.00 | 122 |
| 2022 Q2 | 125,590,881 | $807,500,039 | +$40,235,857 | $6.43 | 111 |
| 2022 Q1 | 119,405,403 | $985,831,531 | +$36,653,787 | $8.26 | 109 |
| 2021 Q4 | 111,562,858 | $1,727,117,718 | +$20,231,159 | $15.48 | 101 |
| 2021 Q3 | 75,725,736 | $1,706,389,522 | +$266,392,448 | $22.52 | 85 |
| 2021 Q2 | 64,059,346 | $1,259,281,145 | +$104,914,051 | $19.66 | 78 |
| 2021 Q1 | 58,277,829 | $1,950,553,711 | +$1,950,553,686 | $33.47 | 74 |